399 related articles for article (PubMed ID: 17347322)
1. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
[TBL] [Abstract][Full Text] [Related]
2. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
3. Activation of cathepsin B involved in enkephalin production by bradykinin and its cleavage products in cultured fibroblasts of the rat dental pulp.
Zhu BF; Kudo T; Maeda S; Inoki R
J Osaka Univ Dent Sch; 1992 Dec; 32():27-44. PubMed ID: 1341708
[TBL] [Abstract][Full Text] [Related]
4. The response of phospholipase C/protein kinase C and adenylyl cyclase/protein kinase A pathways in porcine theca interna cells to opioid agonist FK 33-824.
Kaminski T
Domest Anim Endocrinol; 2004 Nov; 27(4):379-96. PubMed ID: 15519041
[TBL] [Abstract][Full Text] [Related]
5. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
6. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons.
Berg KA; Zardeneta G; Hargreaves KM; Clarke WP; Milam SB
Neuroscience; 2007 Feb; 144(3):889-97. PubMed ID: 17157995
[TBL] [Abstract][Full Text] [Related]
7. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.
Witkowski G; Szulczyk P
Brain Res; 2006 Jun; 1094(1):92-106. PubMed ID: 16733049
[TBL] [Abstract][Full Text] [Related]
8. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
[TBL] [Abstract][Full Text] [Related]
9. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Na, K-ATPase activity by prostaglandin E1 and [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin.
Woolcock K; Specht SC
Life Sci; 2006 Mar; 78(15):1653-61. PubMed ID: 16460765
[TBL] [Abstract][Full Text] [Related]
11. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
12. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo.
Varga A; Bölcskei K; Szöke E; Almási R; Czéh G; Szolcsányi J; Pethö G
Neuroscience; 2006 Jun; 140(2):645-57. PubMed ID: 16564637
[TBL] [Abstract][Full Text] [Related]
13. Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia.
Jeske NA; Berg KA; Cousins JC; Ferro ES; Clarke WP; Glucksman MJ; Roberts JL
J Neurochem; 2006 Apr; 97(1):13-21. PubMed ID: 16515556
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
15. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain.
Shaqura MA; Zöllner C; Mousa SA; Stein C; Schäfer M
J Pharmacol Exp Ther; 2004 Feb; 308(2):712-8. PubMed ID: 14593084
[TBL] [Abstract][Full Text] [Related]
17. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
18. Activation of osteoblastic functions by a mediator of pain, bradykinin.
Kondo A; Togari A
Biochem Pharmacol; 2004 Oct; 68(7):1423-31. PubMed ID: 15345332
[TBL] [Abstract][Full Text] [Related]
19. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
